- Home
- GSBC vs TXMD Comparison
GSBC vs TXMD Comparison
Compare GSBC & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBC
- TXMD
- Stock Information
- Founded
- GSBC 1923
- TXMD 2008
- Country
- GSBC United States
- TXMD United States
- Employees
- GSBC N/A
- TXMD N/A
- Industry
- GSBC Major Banks
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- GSBC Finance
- TXMD Health Care
- Exchange
- GSBC Nasdaq
- TXMD Nasdaq
- Market Cap
- GSBC 665.7M
- TXMD 12.8M
- IPO Year
- GSBC N/A
- TXMD N/A
- Fundamental
- Price
- GSBC $62.51
- TXMD $1.18
- Analyst Decision
- GSBC Hold
- TXMD
- Analyst Count
- GSBC 2
- TXMD 0
- Target Price
- GSBC $59.50
- TXMD N/A
- AVG Volume (30 Days)
- GSBC 84.2K
- TXMD 45.8K
- Earning Date
- GSBC 07-16-2025
- TXMD 08-11-2025
- Dividend Yield
- GSBC 2.56%
- TXMD N/A
- EPS Growth
- GSBC 10.52
- TXMD N/A
- EPS
- GSBC 5.60
- TXMD N/A
- Revenue
- GSBC $219,572,000.00
- TXMD $1,841,000.00
- Revenue This Year
- GSBC N/A
- TXMD $427.09
- Revenue Next Year
- GSBC $1.04
- TXMD N/A
- P/E Ratio
- GSBC $11.16
- TXMD N/A
- Revenue Growth
- GSBC N/A
- TXMD 53.55
- 52 Week Low
- GSBC $47.58
- TXMD $0.70
- 52 Week High
- GSBC $68.02
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- GSBC 72.96
- TXMD 48.98
- Support Level
- GSBC $58.58
- TXMD $0.98
- Resistance Level
- GSBC $60.00
- TXMD $1.21
- Average True Range (ATR)
- GSBC 1.35
- TXMD 0.09
- MACD
- GSBC 0.59
- TXMD 0.01
- Stochastic Oscillator
- GSBC 95.08
- TXMD 80.00
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.